Satoshi Kitai

2.5k total citations
65 papers, 2.0k citations indexed

About

Satoshi Kitai is a scholar working on Hepatology, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, Satoshi Kitai has authored 65 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Hepatology, 32 papers in Epidemiology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Satoshi Kitai's work include Hepatocellular Carcinoma Treatment and Prognosis (38 papers), Liver Disease Diagnosis and Treatment (27 papers) and Hepatitis C virus research (13 papers). Satoshi Kitai is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (38 papers), Liver Disease Diagnosis and Treatment (27 papers) and Hepatitis C virus research (13 papers). Satoshi Kitai collaborates with scholars based in Japan, United States and China. Satoshi Kitai's co-authors include Masatoshi Kudo, Tatsuo Inoue, Kazuomi Ueshima, Yasunori Minami, Satoru Hagiwara, Hobyung Chung, Norihisa Yada, Masahiro Takita, Chie Tatsumi and Taisuke Ueda and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Journal of Applied Physics.

In The Last Decade

Satoshi Kitai

64 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Satoshi Kitai Japan	28	1.5k	952	356	284	237	65	2.0k
Norihisa Yada Japan	28	1.3k 0.9×	993 1.0×	305 0.9×	313 1.1×	248 1.0×	70	1.9k
Tatsuo Inoue Japan	29	1.7k 1.1×	1.1k 1.2×	385 1.1×	337 1.2×	235 1.0×	69	2.3k
Olivier Séror France	26	1.8k 1.2×	1.2k 1.2×	582 1.6×	369 1.3×	162 0.7×	102	2.7k
Yasuhiro Sone Japan	27	1.4k 1.0×	1.2k 1.3×	315 0.9×	191 0.7×	84 0.4×	78	2.0k
Kaoru Tsuchiya Japan	30	2.5k 1.7×	2.0k 2.1×	357 1.0×	153 0.5×	325 1.4×	140	3.2k
Takahide Nakazawa Japan	20	1.1k 0.8×	691 0.7×	327 0.9×	125 0.4×	131 0.6×	60	1.4k
Chikara Ogawa Japan	15	872 0.6×	431 0.5×	205 0.6×	118 0.4×	247 1.0×	50	1.2k
Ryota Masuzaki Japan	24	2.1k 1.4×	1.7k 1.8×	610 1.7×	232 0.8×	149 0.6×	95	3.2k
Xiao-Jun Lin China	16	2.2k 1.5×	1.3k 1.4×	960 2.7×	146 0.5×	199 0.8×	24	2.6k
Wonseok Kang South Korea	26	969 0.7×	1.0k 1.1×	326 0.9×	110 0.4×	322 1.4×	128	2.3k

Countries citing papers authored by Satoshi Kitai

Since Specialization

Citations

This map shows the geographic impact of Satoshi Kitai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Kitai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Kitai more than expected).

Fields of papers citing papers by Satoshi Kitai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoshi Kitai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Kitai. The network helps show where Satoshi Kitai may publish in the future.

Co-authorship network of co-authors of Satoshi Kitai

This figure shows the co-authorship network connecting the top 25 collaborators of Satoshi Kitai. A scholar is included among the top collaborators of Satoshi Kitai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoshi Kitai. Satoshi Kitai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Arizumi, Tadaaki, Kazuomi Ueshima, Tomohiro Minami, et al.. (2015). Validation of a Modified Substaging System (Kinki Criteria) for Patients with Intermediate-Stage Hepatocellular Carcinoma. Oncology. 89(Suppl. 2). 47–52. 31 indexed citations

Nishida, Naoshi, Tomohiro Minami, Hirokazu Chishina, et al.. (2015). Early Viral Response Predicts the Efficacy of Antiviral Triple Therapy with Simeprevir, Peg-Interferon and Ribavirin in Patients Infected with Hepatitis C Virus Genotype 1. Digestive Diseases. 33(6). 708–714. 1 indexed citations

Minami, Yasunori, Tomohiro Minami, Hirokazu Chishina, et al.. (2015). Balloon-Occluded Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: A Single-Center Experience. Oncology. 89(Suppl. 2). 27–32. 20 indexed citations

Kono, Masashi, Tatsuo Inoue, Masatoshi Kudo, et al.. (2014). Radiofrequency Ablation for Hepatocellular Carcinoma Measuring 2 cm or Smaller: Results and Risk Factors for Local Recurrence. Digestive Diseases. 32(6). 670–677. 30 indexed citations

Arizumi, Tadaaki, Kazuomi Ueshima, Haruhiko Takeda, et al.. (2014). Comparison of systems for assessment of post-therapeutic response to sorafenib for hepatocellular carcinoma. Journal of Gastroenterology. 49(12). 1578–1587. 31 indexed citations

Nishida, Naoshi, Hirokazu Chishina, Tadaaki Arizumi, et al.. (2014). Identification of Epigenetically Inactivated Genes in Human Hepatocellular Carcinoma by Integrative Analyses of Methylation Profiling and Pharmacological Unmasking. Digestive Diseases. 32(6). 740–746. 12 indexed citations

Inoue, Tatsuo, Masatoshi Kudo, Kinuyo Hatanaka, et al.. (2013). Usefulness of Contrast-Enhanced Ultrasonography to Evaluate the Post-Treatment Responses of Radiofrequency Ablation for Hepatocellular Carcinoma: Comparison with Dynamic CT. Oncology. 84(Suppl. 1). 51–57. 32 indexed citations

Nishida, Naoshi, Tadaaki Arizumi, Masahiro Takita, et al.. (2013). Quantification of Tumor DNA in Serum and Vascular Invasion of Human Hepatocellular Carcinoma. Oncology. 84(Suppl. 1). 82–87. 13 indexed citations

Nishida, Naoshi, Masatoshi Kudo, Takafumi Nishimura, et al.. (2013). Unique Association between Global DNA Hypomethylation and Chromosomal Alterations in Human Hepatocellular Carcinoma. PLoS ONE. 8(9). e72312–e72312. 29 indexed citations

10.

Arizumi, Tadaaki, Kazuomi Ueshima, Masahiro Takita, et al.. (2012). Long duration of stable disease may improve overall survival in patients with advanced hepatocellular carcinoma treated with sorafenib. Kanzo. 53(6). 348–350.

11.

Nishida, Naoshi, Tadaaki Arizumi, Masahiro Takita, et al.. (2012). Gender Differences in the Livers of Patients with Hepatocellular Carcinoma and Chronic Hepatitis C Infection. Digestive Diseases. 30(6). 547–553. 6 indexed citations

12.

Takita, Masahiro, Satoru Hagiwara, Tadaaki Arizumi, et al.. (2011). Association of Interleukin-28B and Hepatitis C Genotype 1 with a High Viral Load and Response to Pegylated Interferon plus Ribavirin Therapy. Digestion. 84(Suppl. 1). 56–61. 6 indexed citations

13.

Ueshima, Kazuomi, Masatoshi Kudo, Masahiro Takita, et al.. (2011). Des-γ-Carboxyprothrombin May Be a Promising Biomarker to Determine the Therapeutic Efficacy of Sorafenib for Hepatocellular Carcinoma. Digestive Diseases. 29(3). 321–325. 44 indexed citations

14.

Yada, Norihisa, Masatoshi Kudo, Hobyung Chung, et al.. (2010). PEG-IFNα/RBV Combination Therapy for Chronic Hepatitis C Patients Increases Serum Ferritin Level while It Improves Sustained Viral Response Rate. Intervirology. 53(1). 60–65. 6 indexed citations

15.

Minami, Yasunori, Masatoshi Kudo, Kinuyo Hatanaka, et al.. (2010). Radiofrequency ablation guided by contrast harmonic sonography using perfluorocarbon microbubbles (Sonazoid) for hepatic malignancies: an initial experience. Liver International. 30(5). 759–764. 46 indexed citations

16.

Hatanaka, Kinuyo, Hobyung Chung, Masatoshi Kudo, et al.. (2010). Usefulness of the Post-Vascular Phase of Contrast-Enhanced Ultrasonography with Sonazoid in the Evaluation of Gross Types of Hepatocellular Carcinoma. Oncology. 78(Suppl. 1). 53–59. 28 indexed citations

17.

Inoue, Tatsuo, Masatoshi Kudo, Kinuyo Hatanaka, et al.. (2008). Imaging of Hepatocellular Carcinoma: Qualitative and Quantitative Analysis of Postvascular Phase Contrast-Enhanced Ultrasonography with Sonazoid. Oncology. 75(Suppl. 1). 48–54. 32 indexed citations

18.

Takahashi, Shunsuke, Masatoshi Kudo, Hobyung Chung, et al.. (2007). Initial Treatment Response Is Essential to Improve Survival in Patients with Hepatocellular Carcinoma Who Underwent Curative Radiofrequency Ablation Therapy. Oncology. 72(Suppl. 1). 98–103. 74 indexed citations

19.

Kudo, Masatoshi, Yasuhiro Sakaguchi, Hobyung Chung, et al.. (2007). Long-Term Interferon Maintenance Therapy Improves Survival in Patients with HCV-Related Hepatocellular Carcinoma after Curative Radiofrequency Ablation. Oncology. 72(Suppl. 1). 132–138. 54 indexed citations

20.

Takahashi, Shunsuke, Masatoshi Kudo, Hobyung Chung, et al.. (2007). Outcomes of Nontransplant Potentially Curative Therapy for Early-Stage Hepatocellular Carcinoma in Child-Pugh Stage A Cirrhosis Is Comparable with Liver Transplantation. Digestive Diseases. 25(4). 303–309. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact